Vai al contenuto principale della pagina
Titolo: |
Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014
![]() |
Pubblicazione: | Washington : , : U.S. Government Publishing Office, , 2015 |
Descrizione fisica: | 1 online resource (iv, 217 pages) |
Soggetto topico: | Drugs of abuse - Law and legislation - United States |
Drugs - Law and legislation - United States | |
Drug approval - United States | |
Drug accessibility - United States | |
Soggetto genere / forma: | Legislative hearings. |
Note generali: | Title from title screen (viewed on July 24, 2015). |
Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. | |
"Serial No. 113-147." | |
Nota di bibliografia: | Includes bibliographical references. |
Altri titoli varianti: | Improving predictability and transparency in DEA and FDA regulation |
Titolo autorizzato: | Improving predictability and transparency in DEA and FDA regulation ![]() |
Formato: | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910703844903321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |